Precigen (PGEN) Retained Earnings (2012 - 2026)
Precigen (PGEN) reported Retained Earnings of -$17000.0 for Q1 2026, up 100.0% year-over-year from -$8500.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$2.3 billion in Q4 2025.
Precigen (PGEN) Retained Earnings (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Retained Earnings data on file, last reported at -$17000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$17000.0, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17000.0 (up 100.0% YoY), and the FY2025 annual result was -$2.3 billion, down 19511333.33% from the prior year.
- Retained Earnings advanced to -$17000.0 in Q1 2026 per PGEN's latest filing, from -$2.3 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $12000.0 in Q4 2024 and troughed at -$2.3 billion in Q4 2025.
- A 5-year average of -$877.9 million and a median of -$3.6 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 100.62% in 2024, then tumbled 19511333.33% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$3.5 million in 2022, then soared by 44.18% to -$1.9 million in 2023, then surged by 100.62% to $12000.0 in 2024, then plunged by 19511333.33% to -$2.3 billion in 2025, then surged by 100.0% to -$17000.0 in 2026.
- Business Quant data shows PGEN's Retained Earnings at -$17000.0 in Q1 2026, -$2.3 billion in Q4 2025, and -$2.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -2.34 Bn |
| Sep 30, 2025 | -2.32 Bn |
| Jun 30, 2025 | -2.17 Bn |
| Mar 31, 2025 | -2.14 Bn |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -2.07 Bn |
| Jun 30, 2024 | -2.91 Mn |
| Mar 31, 2024 | -2.80 Mn |
| Dec 31, 2023 | -1.95 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | -2.52 Mn |
| Mar 31, 2023 | -2.70 Mn |
| Dec 31, 2022 | -3.49 Mn |
| Sep 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -1.93 Bn |
| Mar 31, 2022 | -1.92 Bn |
| Dec 31, 2021 | -1.92 Bn |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | -1.86 Bn |